nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—AKR1C3—Bimatoprost—glaucoma	0.254	0.75	CbGbCtD
Doxorubicin—NOS3—glaucoma	0.214	0.549	CbGaD
Doxorubicin—CYP1B1—glaucoma	0.176	0.451	CbGaD
Doxorubicin—CYP2D6—Carteolol—glaucoma	0.0144	0.0424	CbGbCtD
Doxorubicin—CYP2D6—Betaxolol—glaucoma	0.00971	0.0287	CbGbCtD
Doxorubicin—CYP2D6—Methazolamide—glaucoma	0.00736	0.0217	CbGbCtD
Doxorubicin—CYP3A4—Pilocarpine—glaucoma	0.00693	0.0204	CbGbCtD
Doxorubicin—ABCB1—Timolol—glaucoma	0.00664	0.0196	CbGbCtD
Doxorubicin—CYP2D6—Timolol—glaucoma	0.00626	0.0185	CbGbCtD
Doxorubicin—ABCB1—Clonidine—glaucoma	0.00565	0.0167	CbGbCtD
Doxorubicin—CYP3A4—Brinzolamide—glaucoma	0.00543	0.016	CbGbCtD
Doxorubicin—CYP2D6—Clonidine—glaucoma	0.00532	0.0157	CbGbCtD
Doxorubicin—CYP3A4—Dorzolamide—glaucoma	0.00525	0.0155	CbGbCtD
Doxorubicin—CYP3A4—Methazolamide—glaucoma	0.00468	0.0138	CbGbCtD
Doxorubicin—CYP3A4—Acetazolamide—glaucoma	0.00374	0.011	CbGbCtD
Doxorubicin—CYP3A4—Clonidine—glaucoma	0.00338	0.00999	CbGbCtD
Doxorubicin—NOS1—endothelium—glaucoma	0.00175	0.0814	CbGeAlD
Doxorubicin—NOS3—endothelium—glaucoma	0.00133	0.0619	CbGeAlD
Doxorubicin—AKR1A1—eye—glaucoma	0.00114	0.0527	CbGeAlD
Doxorubicin—AKR1A1—retina—glaucoma	0.00113	0.0522	CbGeAlD
Doxorubicin—CBR1—Treprostinil—Latanoprost—glaucoma	0.00112	0.675	CbGdCrCtD
Doxorubicin—NDUFS7—connective tissue—glaucoma	0.000994	0.0462	CbGeAlD
Doxorubicin—Daunorubicin—CYP1B1—glaucoma	0.000883	1	CrCbGaD
Doxorubicin—NOS1—eye—glaucoma	0.000861	0.04	CbGeAlD
Doxorubicin—NDUFS2—eye—glaucoma	0.000855	0.0397	CbGeAlD
Doxorubicin—NOS1—retina—glaucoma	0.000853	0.0396	CbGeAlD
Doxorubicin—NDUFS2—retina—glaucoma	0.000848	0.0393	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—glaucoma	0.000824	0.0383	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—glaucoma	0.000814	0.0378	CbGeAlD
Doxorubicin—DHCR7—retina—glaucoma	0.000795	0.0369	CbGeAlD
Doxorubicin—ABCC6—eye—glaucoma	0.000782	0.0363	CbGeAlD
Doxorubicin—ABCC6—retina—glaucoma	0.000775	0.036	CbGeAlD
Doxorubicin—ABCC6—connective tissue—glaucoma	0.000754	0.035	CbGeAlD
Doxorubicin—YWHAG—eye—glaucoma	0.000736	0.0342	CbGeAlD
Doxorubicin—YWHAG—retina—glaucoma	0.00073	0.0339	CbGeAlD
Doxorubicin—YWHAG—connective tissue—glaucoma	0.00071	0.0329	CbGeAlD
Doxorubicin—RALBP1—eye—glaucoma	0.000665	0.0309	CbGeAlD
Doxorubicin—RALBP1—retina—glaucoma	0.000659	0.0306	CbGeAlD
Doxorubicin—NOS3—connective tissue—glaucoma	0.00063	0.0293	CbGeAlD
Doxorubicin—CBR1—eye—glaucoma	0.000621	0.0288	CbGeAlD
Doxorubicin—NQO1—eye—glaucoma	0.000497	0.0231	CbGeAlD
Doxorubicin—NQO1—retina—glaucoma	0.000493	0.0229	CbGeAlD
Doxorubicin—NQO1—connective tissue—glaucoma	0.000479	0.0223	CbGeAlD
Doxorubicin—CYP1B1—eye—glaucoma	0.000349	0.0162	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—glaucoma	0.000337	0.0156	CbGeAlD
Doxorubicin—TOP2A—Alprenolol—Metipranolol—glaucoma	0.000317	0.191	CbGdCrCtD
Doxorubicin—TOP2A—Alprenolol—Betaxolol—glaucoma	0.000222	0.134	CbGdCrCtD
Doxorubicin—ABCB1—retina—glaucoma	0.000127	0.0059	CbGeAlD
Doxorubicin—Gastrointestinal disorder—Pilocarpine—glaucoma	5.45e-05	0.000349	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Travoprost—glaucoma	5.44e-05	0.000348	CcSEcCtD
Doxorubicin—Loss of consciousness—Clonidine—glaucoma	5.43e-05	0.000347	CcSEcCtD
Doxorubicin—Feeling abnormal—Brinzolamide—glaucoma	5.41e-05	0.000346	CcSEcCtD
Doxorubicin—Mental disorder—Betaxolol—glaucoma	5.41e-05	0.000346	CcSEcCtD
Doxorubicin—Pain—Pilocarpine—glaucoma	5.39e-05	0.000345	CcSEcCtD
Doxorubicin—Constipation—Pilocarpine—glaucoma	5.39e-05	0.000345	CcSEcCtD
Doxorubicin—Cough—Clonidine—glaucoma	5.39e-05	0.000345	CcSEcCtD
Doxorubicin—Sweating—Timolol—glaucoma	5.39e-05	0.000345	CcSEcCtD
Doxorubicin—Dizziness—Apraclonidine—glaucoma	5.38e-05	0.000345	CcSEcCtD
Doxorubicin—Malnutrition—Betaxolol—glaucoma	5.37e-05	0.000344	CcSEcCtD
Doxorubicin—Erythema—Betaxolol—glaucoma	5.37e-05	0.000344	CcSEcCtD
Doxorubicin—Urticaria—Dorzolamide—glaucoma	5.3e-05	0.00034	CcSEcCtD
Doxorubicin—Epistaxis—Timolol—glaucoma	5.3e-05	0.000339	CcSEcCtD
Doxorubicin—Abdominal pain—Dorzolamide—glaucoma	5.28e-05	0.000338	CcSEcCtD
Doxorubicin—Body temperature increased—Dorzolamide—glaucoma	5.28e-05	0.000338	CcSEcCtD
Doxorubicin—Tension—Betaxolol—glaucoma	5.27e-05	0.000338	CcSEcCtD
Doxorubicin—Sinusitis—Timolol—glaucoma	5.27e-05	0.000337	CcSEcCtD
Doxorubicin—Dysgeusia—Betaxolol—glaucoma	5.26e-05	0.000337	CcSEcCtD
Doxorubicin—Arthralgia—Clonidine—glaucoma	5.26e-05	0.000337	CcSEcCtD
Doxorubicin—Chest pain—Clonidine—glaucoma	5.26e-05	0.000337	CcSEcCtD
Doxorubicin—Abdominal pain—Travoprost—glaucoma	5.25e-05	0.000336	CcSEcCtD
Doxorubicin—Agranulocytosis—Timolol—glaucoma	5.24e-05	0.000336	CcSEcCtD
Doxorubicin—Anxiety—Clonidine—glaucoma	5.24e-05	0.000335	CcSEcCtD
Doxorubicin—Asthenia—Acetazolamide—glaucoma	5.23e-05	0.000335	CcSEcCtD
Doxorubicin—Dizziness—Bimatoprost—glaucoma	5.22e-05	0.000334	CcSEcCtD
Doxorubicin—Nervousness—Betaxolol—glaucoma	5.22e-05	0.000334	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	5.22e-05	0.000334	CcSEcCtD
Doxorubicin—Urticaria—Brinzolamide—glaucoma	5.21e-05	0.000334	CcSEcCtD
Doxorubicin—Feeling abnormal—Pilocarpine—glaucoma	5.2e-05	0.000333	CcSEcCtD
Doxorubicin—Discomfort—Clonidine—glaucoma	5.19e-05	0.000332	CcSEcCtD
Doxorubicin—Vomiting—Apraclonidine—glaucoma	5.18e-05	0.000332	CcSEcCtD
Doxorubicin—Muscle spasms—Betaxolol—glaucoma	5.17e-05	0.000331	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Pilocarpine—glaucoma	5.16e-05	0.00033	CcSEcCtD
Doxorubicin—Hypersensitivity—Brimonidine—glaucoma	5.15e-05	0.00033	CcSEcCtD
Doxorubicin—Dry mouth—Clonidine—glaucoma	5.14e-05	0.000329	CcSEcCtD
Doxorubicin—Bradycardia—Timolol—glaucoma	5.13e-05	0.000329	CcSEcCtD
Doxorubicin—Dermatitis—Apraclonidine—glaucoma	5.13e-05	0.000328	CcSEcCtD
Doxorubicin—Headache—Apraclonidine—glaucoma	5.1e-05	0.000327	CcSEcCtD
Doxorubicin—Confusional state—Clonidine—glaucoma	5.08e-05	0.000325	CcSEcCtD
Doxorubicin—Vision blurred—Betaxolol—glaucoma	5.06e-05	0.000324	CcSEcCtD
Doxorubicin—Rhinitis—Timolol—glaucoma	5.06e-05	0.000324	CcSEcCtD
Doxorubicin—Oedema—Clonidine—glaucoma	5.04e-05	0.000323	CcSEcCtD
Doxorubicin—Asthenia—Brimonidine—glaucoma	5.02e-05	0.000321	CcSEcCtD
Doxorubicin—Infection—Clonidine—glaucoma	5e-05	0.00032	CcSEcCtD
Doxorubicin—Abdominal pain—Pilocarpine—glaucoma	4.99e-05	0.000319	CcSEcCtD
Doxorubicin—Body temperature increased—Pilocarpine—glaucoma	4.99e-05	0.000319	CcSEcCtD
Doxorubicin—Ill-defined disorder—Betaxolol—glaucoma	4.99e-05	0.000319	CcSEcCtD
Doxorubicin—Diarrhoea—Acetazolamide—glaucoma	4.98e-05	0.000319	CcSEcCtD
Doxorubicin—Rash—Bimatoprost—glaucoma	4.98e-05	0.000319	CcSEcCtD
Doxorubicin—Dermatitis—Bimatoprost—glaucoma	4.97e-05	0.000318	CcSEcCtD
Doxorubicin—Oedema peripheral—Timolol—glaucoma	4.97e-05	0.000318	CcSEcCtD
Doxorubicin—Anaemia—Betaxolol—glaucoma	4.97e-05	0.000318	CcSEcCtD
Doxorubicin—Shock—Clonidine—glaucoma	4.96e-05	0.000317	CcSEcCtD
Doxorubicin—Connective tissue disorder—Timolol—glaucoma	4.96e-05	0.000317	CcSEcCtD
Doxorubicin—Pruritus—Brimonidine—glaucoma	4.95e-05	0.000317	CcSEcCtD
Doxorubicin—Headache—Bimatoprost—glaucoma	4.95e-05	0.000317	CcSEcCtD
Doxorubicin—Nervous system disorder—Clonidine—glaucoma	4.94e-05	0.000316	CcSEcCtD
Doxorubicin—Thrombocytopenia—Clonidine—glaucoma	4.93e-05	0.000316	CcSEcCtD
Doxorubicin—Hypersensitivity—Dorzolamide—glaucoma	4.92e-05	0.000315	CcSEcCtD
Doxorubicin—Tachycardia—Clonidine—glaucoma	4.92e-05	0.000315	CcSEcCtD
Doxorubicin—Hypersensitivity—Travoprost—glaucoma	4.9e-05	0.000314	CcSEcCtD
Doxorubicin—Skin disorder—Clonidine—glaucoma	4.89e-05	0.000313	CcSEcCtD
Doxorubicin—Hyperhidrosis—Clonidine—glaucoma	4.87e-05	0.000312	CcSEcCtD
Doxorubicin—Visual impairment—Timolol—glaucoma	4.86e-05	0.000311	CcSEcCtD
Doxorubicin—Malaise—Betaxolol—glaucoma	4.85e-05	0.00031	CcSEcCtD
Doxorubicin—Nausea—Apraclonidine—glaucoma	4.84e-05	0.00031	CcSEcCtD
Doxorubicin—Hypersensitivity—Brinzolamide—glaucoma	4.84e-05	0.00031	CcSEcCtD
Doxorubicin—Vertigo—Betaxolol—glaucoma	4.83e-05	0.000309	CcSEcCtD
Doxorubicin—Syncope—Betaxolol—glaucoma	4.82e-05	0.000309	CcSEcCtD
Doxorubicin—Dizziness—Acetazolamide—glaucoma	4.82e-05	0.000308	CcSEcCtD
Doxorubicin—Anorexia—Clonidine—glaucoma	4.8e-05	0.000307	CcSEcCtD
Doxorubicin—Asthenia—Dorzolamide—glaucoma	4.79e-05	0.000307	CcSEcCtD
Doxorubicin—Asthenia—Travoprost—glaucoma	4.77e-05	0.000305	CcSEcCtD
Doxorubicin—Palpitations—Betaxolol—glaucoma	4.75e-05	0.000304	CcSEcCtD
Doxorubicin—Pruritus—Dorzolamide—glaucoma	4.72e-05	0.000302	CcSEcCtD
Doxorubicin—Loss of consciousness—Betaxolol—glaucoma	4.72e-05	0.000302	CcSEcCtD
Doxorubicin—Eye disorder—Timolol—glaucoma	4.71e-05	0.000302	CcSEcCtD
Doxorubicin—Asthenia—Brinzolamide—glaucoma	4.71e-05	0.000302	CcSEcCtD
Doxorubicin—Hypotension—Clonidine—glaucoma	4.71e-05	0.000301	CcSEcCtD
Doxorubicin—Pruritus—Travoprost—glaucoma	4.7e-05	0.000301	CcSEcCtD
Doxorubicin—Tinnitus—Timolol—glaucoma	4.7e-05	0.000301	CcSEcCtD
Doxorubicin—Cough—Betaxolol—glaucoma	4.69e-05	0.0003	CcSEcCtD
Doxorubicin—Nausea—Bimatoprost—glaucoma	4.69e-05	0.0003	CcSEcCtD
Doxorubicin—Cardiac disorder—Timolol—glaucoma	4.68e-05	0.0003	CcSEcCtD
Doxorubicin—Hypersensitivity—Pilocarpine—glaucoma	4.65e-05	0.000298	CcSEcCtD
Doxorubicin—Pruritus—Brinzolamide—glaucoma	4.64e-05	0.000297	CcSEcCtD
Doxorubicin—Vomiting—Acetazolamide—glaucoma	4.63e-05	0.000297	CcSEcCtD
Doxorubicin—Dizziness—Brimonidine—glaucoma	4.62e-05	0.000296	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Clonidine—glaucoma	4.59e-05	0.000294	CcSEcCtD
Doxorubicin—Angiopathy—Timolol—glaucoma	4.58e-05	0.000293	CcSEcCtD
Doxorubicin—Myalgia—Betaxolol—glaucoma	4.58e-05	0.000293	CcSEcCtD
Doxorubicin—Chest pain—Betaxolol—glaucoma	4.58e-05	0.000293	CcSEcCtD
Doxorubicin—Arthralgia—Betaxolol—glaucoma	4.58e-05	0.000293	CcSEcCtD
Doxorubicin—Diarrhoea—Dorzolamide—glaucoma	4.57e-05	0.000293	CcSEcCtD
Doxorubicin—Headache—Acetazolamide—glaucoma	4.56e-05	0.000292	CcSEcCtD
Doxorubicin—Anxiety—Betaxolol—glaucoma	4.56e-05	0.000292	CcSEcCtD
Doxorubicin—Insomnia—Clonidine—glaucoma	4.56e-05	0.000292	CcSEcCtD
Doxorubicin—Immune system disorder—Timolol—glaucoma	4.56e-05	0.000292	CcSEcCtD
Doxorubicin—Diarrhoea—Travoprost—glaucoma	4.55e-05	0.000291	CcSEcCtD
Doxorubicin—Mediastinal disorder—Timolol—glaucoma	4.55e-05	0.000291	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	4.54e-05	0.000291	CcSEcCtD
Doxorubicin—Asthenia—Pilocarpine—glaucoma	4.53e-05	0.00029	CcSEcCtD
Doxorubicin—Paraesthesia—Clonidine—glaucoma	4.52e-05	0.00029	CcSEcCtD
Doxorubicin—Discomfort—Betaxolol—glaucoma	4.52e-05	0.000289	CcSEcCtD
Doxorubicin—Arrhythmia—Timolol—glaucoma	4.51e-05	0.000288	CcSEcCtD
Doxorubicin—Dyspnoea—Clonidine—glaucoma	4.49e-05	0.000288	CcSEcCtD
Doxorubicin—Diarrhoea—Brinzolamide—glaucoma	4.49e-05	0.000288	CcSEcCtD
Doxorubicin—Somnolence—Clonidine—glaucoma	4.48e-05	0.000287	CcSEcCtD
Doxorubicin—Dry mouth—Betaxolol—glaucoma	4.47e-05	0.000287	CcSEcCtD
Doxorubicin—Pruritus—Pilocarpine—glaucoma	4.46e-05	0.000286	CcSEcCtD
Doxorubicin—Alopecia—Timolol—glaucoma	4.46e-05	0.000285	CcSEcCtD
Doxorubicin—Confusional state—Betaxolol—glaucoma	4.42e-05	0.000283	CcSEcCtD
Doxorubicin—Mental disorder—Timolol—glaucoma	4.42e-05	0.000283	CcSEcCtD
Doxorubicin—Dizziness—Dorzolamide—glaucoma	4.41e-05	0.000283	CcSEcCtD
Doxorubicin—Rash—Brimonidine—glaucoma	4.41e-05	0.000282	CcSEcCtD
Doxorubicin—Dermatitis—Brimonidine—glaucoma	4.4e-05	0.000282	CcSEcCtD
Doxorubicin—Dizziness—Travoprost—glaucoma	4.4e-05	0.000281	CcSEcCtD
Doxorubicin—Erythema—Timolol—glaucoma	4.39e-05	0.000281	CcSEcCtD
Doxorubicin—Malnutrition—Timolol—glaucoma	4.39e-05	0.000281	CcSEcCtD
Doxorubicin—Oedema—Betaxolol—glaucoma	4.39e-05	0.000281	CcSEcCtD
Doxorubicin—Headache—Brimonidine—glaucoma	4.38e-05	0.00028	CcSEcCtD
Doxorubicin—Decreased appetite—Clonidine—glaucoma	4.38e-05	0.00028	CcSEcCtD
Doxorubicin—Infection—Betaxolol—glaucoma	4.36e-05	0.000279	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Clonidine—glaucoma	4.35e-05	0.000279	CcSEcCtD
Doxorubicin—Fatigue—Clonidine—glaucoma	4.34e-05	0.000278	CcSEcCtD
Doxorubicin—Dizziness—Brinzolamide—glaucoma	4.34e-05	0.000278	CcSEcCtD
Doxorubicin—Nausea—Acetazolamide—glaucoma	4.33e-05	0.000277	CcSEcCtD
Doxorubicin—Diarrhoea—Pilocarpine—glaucoma	4.32e-05	0.000276	CcSEcCtD
Doxorubicin—Shock—Betaxolol—glaucoma	4.31e-05	0.000276	CcSEcCtD
Doxorubicin—Tension—Timolol—glaucoma	4.31e-05	0.000276	CcSEcCtD
Doxorubicin—Pain—Clonidine—glaucoma	4.31e-05	0.000276	CcSEcCtD
Doxorubicin—Constipation—Clonidine—glaucoma	4.31e-05	0.000276	CcSEcCtD
Doxorubicin—Nervous system disorder—Betaxolol—glaucoma	4.3e-05	0.000275	CcSEcCtD
Doxorubicin—Dysgeusia—Timolol—glaucoma	4.3e-05	0.000275	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betaxolol—glaucoma	4.29e-05	0.000275	CcSEcCtD
Doxorubicin—Tachycardia—Betaxolol—glaucoma	4.28e-05	0.000274	CcSEcCtD
Doxorubicin—Nervousness—Timolol—glaucoma	4.26e-05	0.000273	CcSEcCtD
Doxorubicin—Skin disorder—Betaxolol—glaucoma	4.26e-05	0.000273	CcSEcCtD
Doxorubicin—Vomiting—Dorzolamide—glaucoma	4.24e-05	0.000272	CcSEcCtD
Doxorubicin—Hyperhidrosis—Betaxolol—glaucoma	4.24e-05	0.000272	CcSEcCtD
Doxorubicin—Rash—Dorzolamide—glaucoma	4.21e-05	0.00027	CcSEcCtD
Doxorubicin—Dermatitis—Dorzolamide—glaucoma	4.21e-05	0.000269	CcSEcCtD
Doxorubicin—Rash—Travoprost—glaucoma	4.19e-05	0.000268	CcSEcCtD
Doxorubicin—Dermatitis—Travoprost—glaucoma	4.19e-05	0.000268	CcSEcCtD
Doxorubicin—Headache—Dorzolamide—glaucoma	4.18e-05	0.000268	CcSEcCtD
Doxorubicin—Anorexia—Betaxolol—glaucoma	4.18e-05	0.000268	CcSEcCtD
Doxorubicin—Vomiting—Brinzolamide—glaucoma	4.17e-05	0.000267	CcSEcCtD
Doxorubicin—Dizziness—Pilocarpine—glaucoma	4.17e-05	0.000267	CcSEcCtD
Doxorubicin—Headache—Travoprost—glaucoma	4.16e-05	0.000267	CcSEcCtD
Doxorubicin—Nausea—Brimonidine—glaucoma	4.15e-05	0.000266	CcSEcCtD
Doxorubicin—Feeling abnormal—Clonidine—glaucoma	4.15e-05	0.000266	CcSEcCtD
Doxorubicin—Rash—Brinzolamide—glaucoma	4.14e-05	0.000265	CcSEcCtD
Doxorubicin—Vision blurred—Timolol—glaucoma	4.14e-05	0.000265	CcSEcCtD
Doxorubicin—Dermatitis—Brinzolamide—glaucoma	4.13e-05	0.000265	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Clonidine—glaucoma	4.12e-05	0.000264	CcSEcCtD
Doxorubicin—Headache—Brinzolamide—glaucoma	4.11e-05	0.000263	CcSEcCtD
Doxorubicin—Hypotension—Betaxolol—glaucoma	4.1e-05	0.000262	CcSEcCtD
Doxorubicin—Vomiting—Pilocarpine—glaucoma	4.01e-05	0.000257	CcSEcCtD
Doxorubicin—Urticaria—Clonidine—glaucoma	4e-05	0.000256	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betaxolol—glaucoma	4e-05	0.000256	CcSEcCtD
Doxorubicin—Body temperature increased—Clonidine—glaucoma	3.98e-05	0.000255	CcSEcCtD
Doxorubicin—Abdominal pain—Clonidine—glaucoma	3.98e-05	0.000255	CcSEcCtD
Doxorubicin—Rash—Pilocarpine—glaucoma	3.98e-05	0.000255	CcSEcCtD
Doxorubicin—Dermatitis—Pilocarpine—glaucoma	3.97e-05	0.000254	CcSEcCtD
Doxorubicin—Insomnia—Betaxolol—glaucoma	3.97e-05	0.000254	CcSEcCtD
Doxorubicin—Nausea—Dorzolamide—glaucoma	3.97e-05	0.000254	CcSEcCtD
Doxorubicin—Headache—Pilocarpine—glaucoma	3.95e-05	0.000253	CcSEcCtD
Doxorubicin—Nausea—Travoprost—glaucoma	3.95e-05	0.000253	CcSEcCtD
Doxorubicin—Vertigo—Timolol—glaucoma	3.94e-05	0.000253	CcSEcCtD
Doxorubicin—Paraesthesia—Betaxolol—glaucoma	3.94e-05	0.000252	CcSEcCtD
Doxorubicin—Syncope—Timolol—glaucoma	3.94e-05	0.000252	CcSEcCtD
Doxorubicin—Dyspnoea—Betaxolol—glaucoma	3.91e-05	0.00025	CcSEcCtD
Doxorubicin—Nausea—Brinzolamide—glaucoma	3.9e-05	0.00025	CcSEcCtD
Doxorubicin—Palpitations—Timolol—glaucoma	3.88e-05	0.000248	CcSEcCtD
Doxorubicin—Dyspepsia—Betaxolol—glaucoma	3.86e-05	0.000247	CcSEcCtD
Doxorubicin—Loss of consciousness—Timolol—glaucoma	3.86e-05	0.000247	CcSEcCtD
Doxorubicin—Cough—Timolol—glaucoma	3.83e-05	0.000245	CcSEcCtD
Doxorubicin—Decreased appetite—Betaxolol—glaucoma	3.81e-05	0.000244	CcSEcCtD
Doxorubicin—Hypertension—Timolol—glaucoma	3.79e-05	0.000243	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betaxolol—glaucoma	3.79e-05	0.000242	CcSEcCtD
Doxorubicin—Fatigue—Betaxolol—glaucoma	3.78e-05	0.000242	CcSEcCtD
Doxorubicin—Constipation—Betaxolol—glaucoma	3.75e-05	0.00024	CcSEcCtD
Doxorubicin—Pain—Betaxolol—glaucoma	3.75e-05	0.00024	CcSEcCtD
Doxorubicin—Nausea—Pilocarpine—glaucoma	3.75e-05	0.00024	CcSEcCtD
Doxorubicin—Chest pain—Timolol—glaucoma	3.74e-05	0.000239	CcSEcCtD
Doxorubicin—Myalgia—Timolol—glaucoma	3.74e-05	0.000239	CcSEcCtD
Doxorubicin—Arthralgia—Timolol—glaucoma	3.74e-05	0.000239	CcSEcCtD
Doxorubicin—Anxiety—Timolol—glaucoma	3.72e-05	0.000239	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	3.71e-05	0.000238	CcSEcCtD
Doxorubicin—Hypersensitivity—Clonidine—glaucoma	3.71e-05	0.000238	CcSEcCtD
Doxorubicin—Discomfort—Timolol—glaucoma	3.69e-05	0.000236	CcSEcCtD
Doxorubicin—Dry mouth—Timolol—glaucoma	3.66e-05	0.000234	CcSEcCtD
Doxorubicin—Asthenia—Clonidine—glaucoma	3.61e-05	0.000231	CcSEcCtD
Doxorubicin—Feeling abnormal—Betaxolol—glaucoma	3.61e-05	0.000231	CcSEcCtD
Doxorubicin—Confusional state—Timolol—glaucoma	3.61e-05	0.000231	CcSEcCtD
Doxorubicin—Oedema—Timolol—glaucoma	3.58e-05	0.000229	CcSEcCtD
Doxorubicin—Anaphylactic shock—Timolol—glaucoma	3.58e-05	0.000229	CcSEcCtD
Doxorubicin—Pruritus—Clonidine—glaucoma	3.56e-05	0.000228	CcSEcCtD
Doxorubicin—Infection—Timolol—glaucoma	3.56e-05	0.000228	CcSEcCtD
Doxorubicin—Shock—Timolol—glaucoma	3.53e-05	0.000226	CcSEcCtD
Doxorubicin—Nervous system disorder—Timolol—glaucoma	3.51e-05	0.000225	CcSEcCtD
Doxorubicin—Urticaria—Betaxolol—glaucoma	3.48e-05	0.000223	CcSEcCtD
Doxorubicin—Skin disorder—Timolol—glaucoma	3.48e-05	0.000223	CcSEcCtD
Doxorubicin—Body temperature increased—Betaxolol—glaucoma	3.47e-05	0.000222	CcSEcCtD
Doxorubicin—Hyperhidrosis—Timolol—glaucoma	3.46e-05	0.000222	CcSEcCtD
Doxorubicin—Diarrhoea—Clonidine—glaucoma	3.45e-05	0.000221	CcSEcCtD
Doxorubicin—Anorexia—Timolol—glaucoma	3.42e-05	0.000219	CcSEcCtD
Doxorubicin—Hypotension—Timolol—glaucoma	3.35e-05	0.000214	CcSEcCtD
Doxorubicin—Dizziness—Clonidine—glaucoma	3.33e-05	0.000213	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Timolol—glaucoma	3.26e-05	0.000209	CcSEcCtD
Doxorubicin—Insomnia—Timolol—glaucoma	3.24e-05	0.000208	CcSEcCtD
Doxorubicin—Hypersensitivity—Betaxolol—glaucoma	3.23e-05	0.000207	CcSEcCtD
Doxorubicin—Paraesthesia—Timolol—glaucoma	3.22e-05	0.000206	CcSEcCtD
Doxorubicin—Vomiting—Clonidine—glaucoma	3.2e-05	0.000205	CcSEcCtD
Doxorubicin—Dyspnoea—Timolol—glaucoma	3.19e-05	0.000205	CcSEcCtD
Doxorubicin—Somnolence—Timolol—glaucoma	3.19e-05	0.000204	CcSEcCtD
Doxorubicin—Rash—Clonidine—glaucoma	3.18e-05	0.000203	CcSEcCtD
Doxorubicin—Dermatitis—Clonidine—glaucoma	3.17e-05	0.000203	CcSEcCtD
Doxorubicin—Headache—Clonidine—glaucoma	3.16e-05	0.000202	CcSEcCtD
Doxorubicin—Dyspepsia—Timolol—glaucoma	3.15e-05	0.000202	CcSEcCtD
Doxorubicin—Asthenia—Betaxolol—glaucoma	3.15e-05	0.000202	CcSEcCtD
Doxorubicin—Decreased appetite—Timolol—glaucoma	3.11e-05	0.000199	CcSEcCtD
Doxorubicin—Pruritus—Betaxolol—glaucoma	3.1e-05	0.000199	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Timolol—glaucoma	3.09e-05	0.000198	CcSEcCtD
Doxorubicin—Fatigue—Timolol—glaucoma	3.09e-05	0.000198	CcSEcCtD
Doxorubicin—Pain—Timolol—glaucoma	3.06e-05	0.000196	CcSEcCtD
Doxorubicin—Diarrhoea—Betaxolol—glaucoma	3e-05	0.000192	CcSEcCtD
Doxorubicin—Nausea—Clonidine—glaucoma	2.99e-05	0.000192	CcSEcCtD
Doxorubicin—Feeling abnormal—Timolol—glaucoma	2.95e-05	0.000189	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Timolol—glaucoma	2.93e-05	0.000188	CcSEcCtD
Doxorubicin—Dizziness—Betaxolol—glaucoma	2.9e-05	0.000186	CcSEcCtD
Doxorubicin—Urticaria—Timolol—glaucoma	2.85e-05	0.000182	CcSEcCtD
Doxorubicin—Body temperature increased—Timolol—glaucoma	2.83e-05	0.000181	CcSEcCtD
Doxorubicin—Abdominal pain—Timolol—glaucoma	2.83e-05	0.000181	CcSEcCtD
Doxorubicin—Vomiting—Betaxolol—glaucoma	2.79e-05	0.000179	CcSEcCtD
Doxorubicin—Rash—Betaxolol—glaucoma	2.77e-05	0.000177	CcSEcCtD
Doxorubicin—Dermatitis—Betaxolol—glaucoma	2.76e-05	0.000177	CcSEcCtD
Doxorubicin—Headache—Betaxolol—glaucoma	2.75e-05	0.000176	CcSEcCtD
Doxorubicin—Hypersensitivity—Timolol—glaucoma	2.64e-05	0.000169	CcSEcCtD
Doxorubicin—Nausea—Betaxolol—glaucoma	2.61e-05	0.000167	CcSEcCtD
Doxorubicin—Asthenia—Timolol—glaucoma	2.57e-05	0.000165	CcSEcCtD
Doxorubicin—Pruritus—Timolol—glaucoma	2.53e-05	0.000162	CcSEcCtD
Doxorubicin—Diarrhoea—Timolol—glaucoma	2.45e-05	0.000157	CcSEcCtD
Doxorubicin—Dizziness—Timolol—glaucoma	2.37e-05	0.000152	CcSEcCtD
Doxorubicin—Vomiting—Timolol—glaucoma	2.28e-05	0.000146	CcSEcCtD
Doxorubicin—Rash—Timolol—glaucoma	2.26e-05	0.000145	CcSEcCtD
Doxorubicin—Dermatitis—Timolol—glaucoma	2.26e-05	0.000145	CcSEcCtD
Doxorubicin—Headache—Timolol—glaucoma	2.24e-05	0.000144	CcSEcCtD
Doxorubicin—Nausea—Timolol—glaucoma	2.13e-05	0.000136	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—SMO—glaucoma	1.28e-05	0.000141	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.26e-05	0.000139	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.26e-05	0.000139	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTGS2—glaucoma	1.26e-05	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN2B—glaucoma	1.26e-05	0.000138	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.25e-05	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ABCA1—glaucoma	1.25e-05	0.000137	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CYP1B1—glaucoma	1.25e-05	0.000137	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—APOE—glaucoma	1.24e-05	0.000136	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CAV1—glaucoma	1.23e-05	0.000135	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.21e-05	0.000133	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HDAC9—glaucoma	1.2e-05	0.000132	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.2e-05	0.000132	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—glaucoma	1.19e-05	0.000131	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—VEGFA—glaucoma	1.19e-05	0.000131	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.18e-05	0.00013	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.18e-05	0.00013	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NTRK2—glaucoma	1.17e-05	0.000129	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—NOS3—glaucoma	1.17e-05	0.000129	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—FN1—glaucoma	1.17e-05	0.000128	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	1.17e-05	0.000128	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CYP1B1—glaucoma	1.16e-05	0.000128	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ABCA1—glaucoma	1.16e-05	0.000128	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—BAD—glaucoma	1.16e-05	0.000127	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MTHFR—glaucoma	1.15e-05	0.000126	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.1e-05	0.000121	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—glaucoma	1.09e-05	0.00012	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—NOS3—glaucoma	1.09e-05	0.00012	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.09e-05	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SMO—glaucoma	1.08e-05	0.000119	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GSTT1—glaucoma	1.07e-05	0.000118	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—glaucoma	1.07e-05	0.000118	CbGpPWpGaD
Doxorubicin—NOS2—Disease—APOE—glaucoma	1.07e-05	0.000117	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN2B—glaucoma	1.06e-05	0.000117	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NOS3—glaucoma	1.06e-05	0.000117	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CAV1—glaucoma	1.06e-05	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP1B1—glaucoma	1.06e-05	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ABCA1—glaucoma	1.06e-05	0.000116	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MTHFR—glaucoma	1.05e-05	0.000116	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN2A—glaucoma	1.04e-05	0.000115	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CA1—glaucoma	1.04e-05	0.000114	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TXN—glaucoma	1.04e-05	0.000114	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GSTM1—glaucoma	1.04e-05	0.000114	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	1.03e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GSTT1—glaucoma	1.03e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—glaucoma	1.01e-05	0.000111	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CTSA—glaucoma	1.01e-05	0.000111	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.01e-05	0.000111	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TXN—glaucoma	1.01e-05	0.000111	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NGFR—glaucoma	1.01e-05	0.00011	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—glaucoma	1e-05	0.00011	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GSTM1—glaucoma	9.99e-06	0.00011	CbGpPWpGaD
Doxorubicin—NOS2—Disease—BAD—glaucoma	9.95e-06	0.000109	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NTRK2—glaucoma	9.9e-06	0.000109	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—APOE—glaucoma	9.81e-06	0.000108	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CAV1—glaucoma	9.72e-06	0.000107	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—glaucoma	9.7e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA5A—glaucoma	9.7e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NARFL—glaucoma	9.7e-06	0.000107	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NTRK1—glaucoma	9.55e-06	0.000105	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CA2—glaucoma	9.53e-06	0.000105	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.5e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.42e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.41e-06	0.000103	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NOS3—glaucoma	9.29e-06	0.000102	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GSTM1—glaucoma	9.28e-06	0.000102	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—VEGFA—glaucoma	9.24e-06	0.000102	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN1B—glaucoma	9.23e-06	0.000101	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.19e-06	0.000101	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CDKN1B—glaucoma	9.19e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TXN—glaucoma	9.16e-06	0.000101	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MTHFR—glaucoma	9.15e-06	0.000101	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—BAD—glaucoma	9.14e-06	0.0001	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.1e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—glaucoma	8.99e-06	9.88e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTHFR—glaucoma	8.9e-06	9.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTHFR—glaucoma	8.83e-06	9.7e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.81e-06	9.68e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN2B—glaucoma	8.8e-06	9.67e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.69e-06	9.55e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.66e-06	9.52e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ABCA1—glaucoma	8.56e-06	9.41e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP1B1—glaucoma	8.56e-06	9.41e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—APOE—glaucoma	8.52e-06	9.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NGFR—glaucoma	8.5e-06	9.33e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EDN1—glaucoma	8.45e-06	9.28e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CAV1—glaucoma	8.44e-06	9.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GSTM1—glaucoma	8.44e-06	9.27e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.31e-06	9.13e-05	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—glaucoma	8.3e-06	9.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—APOE—glaucoma	8.29e-06	9.11e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—APOE—glaucoma	8.22e-06	9.03e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CAV1—glaucoma	8.21e-06	9.02e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ABCA1—glaucoma	8.21e-06	9.02e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP1B1—glaucoma	8.21e-06	9.02e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MTHFR—glaucoma	8.2e-06	9.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CAV1—glaucoma	8.14e-06	8.94e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTT1—glaucoma	8.07e-06	8.87e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NTRK1—glaucoma	8.07e-06	8.87e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN1B—glaucoma	8.05e-06	8.84e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NOS3—glaucoma	8e-06	8.79e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTT1—glaucoma	7.81e-06	8.58e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NGF—glaucoma	7.76e-06	8.53e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—BAD—glaucoma	7.72e-06	8.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CA1—glaucoma	7.69e-06	8.44e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—APOE—glaucoma	7.64e-06	8.39e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CAV1—glaucoma	7.57e-06	8.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTHFR—glaucoma	7.46e-06	8.19e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MMP9—glaucoma	7.45e-06	8.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CTSA—glaucoma	7.44e-06	8.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN2B—glaucoma	7.44e-06	8.17e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.42e-06	8.15e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—C3—glaucoma	7.38e-06	8.11e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NOS3—glaucoma	7.35e-06	8.08e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—glaucoma	7.32e-06	8.04e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CA1—glaucoma	7.24e-06	7.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EDN1—glaucoma	7.14e-06	7.84e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTT1—glaucoma	7.1e-06	7.8e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CA2—glaucoma	7.03e-06	7.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.02e-06	7.72e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CTSA—glaucoma	7.01e-06	7.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—glaucoma	6.98e-06	7.67e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—APOE—glaucoma	6.94e-06	7.63e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN1B—glaucoma	6.93e-06	7.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CAV1—glaucoma	6.88e-06	7.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—APOE—glaucoma	6.87e-06	7.55e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GSTM1—glaucoma	6.84e-06	7.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CAV1—glaucoma	6.81e-06	7.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—glaucoma	6.72e-06	7.39e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TXN—glaucoma	6.71e-06	7.38e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—glaucoma	6.69e-06	7.35e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CA2—glaucoma	6.62e-06	7.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GSTM1—glaucoma	6.56e-06	7.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NGF—glaucoma	6.56e-06	7.21e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.51e-06	7.15e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—FN1—glaucoma	6.48e-06	7.12e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN2B—glaucoma	6.47e-06	7.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCA1—glaucoma	6.43e-06	7.07e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP1B1—glaucoma	6.43e-06	7.07e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—BAD—glaucoma	6.4e-06	7.03e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NOS3—glaucoma	6.38e-06	7.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN1B—glaucoma	6.37e-06	7e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.3e-06	6.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—C3—glaucoma	6.24e-06	6.85e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCA1—glaucoma	6.22e-06	6.83e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NOS3—glaucoma	6.16e-06	6.76e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—glaucoma	6.05e-06	6.65e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.84e-06	6.42e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—glaucoma	5.84e-06	6.41e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOE—glaucoma	5.8e-06	6.38e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—glaucoma	5.8e-06	6.37e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—glaucoma	5.8e-06	6.37e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CAV1—glaucoma	5.75e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NOS3—glaucoma	5.72e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—glaucoma	5.68e-06	6.24e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP1B1—glaucoma	5.66e-06	6.22e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCA1—glaucoma	5.66e-06	6.22e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOE—glaucoma	5.63e-06	6.19e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—glaucoma	5.63e-06	6.19e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CAV1—glaucoma	5.58e-06	6.13e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—FN1—glaucoma	5.47e-06	6.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—glaucoma	5.43e-06	5.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—BAD—glaucoma	5.41e-06	5.94e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—glaucoma	5.4e-06	5.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1B—glaucoma	5.38e-06	5.91e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CAV1—glaucoma	5.35e-06	5.88e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—glaucoma	5.23e-06	5.75e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTT1—glaucoma	5.21e-06	5.72e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOS3—glaucoma	5.15e-06	5.66e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTM1—glaucoma	5.14e-06	5.65e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—glaucoma	5.06e-06	5.56e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—glaucoma	5.05e-06	5.55e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.01e-06	5.5e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CAV1—glaucoma	5e-06	5.5e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTM1—glaucoma	4.97e-06	5.46e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TXN—glaucoma	4.95e-06	5.44e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—glaucoma	4.76e-06	5.23e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA1—glaucoma	4.74e-06	5.2e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—BAD—glaucoma	4.71e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TXN—glaucoma	4.67e-06	5.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CTSA—glaucoma	4.59e-06	5.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—glaucoma	4.54e-06	4.99e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTM1—glaucoma	4.52e-06	4.97e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1B—glaucoma	4.46e-06	4.9e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.41e-06	4.85e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—glaucoma	4.39e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA2—glaucoma	4.33e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—glaucoma	4.23e-06	4.65e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NOS3—glaucoma	4.22e-06	4.64e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CAV1—glaucoma	4.19e-06	4.61e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP1B1—glaucoma	4.15e-06	4.56e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCA1—glaucoma	4.15e-06	4.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—glaucoma	4.13e-06	4.54e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—glaucoma	4.09e-06	4.5e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAV1—glaucoma	4.05e-06	4.45e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—glaucoma	4.04e-06	4.44e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—glaucoma	4e-06	4.39e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—glaucoma	3.86e-06	4.24e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTT1—glaucoma	3.84e-06	4.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—glaucoma	3.78e-06	4.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1B—glaucoma	3.77e-06	4.14e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—glaucoma	3.72e-06	4.09e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—glaucoma	3.71e-06	4.07e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—glaucoma	3.7e-06	4.06e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAV1—glaucoma	3.69e-06	4.05e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTT1—glaucoma	3.62e-06	3.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—glaucoma	3.49e-06	3.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—glaucoma	3.46e-06	3.8e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—glaucoma	3.32e-06	3.64e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1B—glaucoma	3.28e-06	3.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—glaucoma	3.17e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—glaucoma	3.13e-06	3.44e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—glaucoma	3.07e-06	3.37e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCA1—glaucoma	3.06e-06	3.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1B1—glaucoma	3.06e-06	3.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TXN—glaucoma	3.05e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—glaucoma	2.93e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—glaucoma	2.9e-06	3.18e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCA1—glaucoma	2.88e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1B1—glaucoma	2.88e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—glaucoma	2.8e-06	3.08e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—glaucoma	2.8e-06	3.08e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—glaucoma	2.79e-06	3.06e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—glaucoma	2.73e-06	3e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAV1—glaucoma	2.7e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—glaucoma	2.55e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—glaucoma	2.45e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—glaucoma	2.37e-06	2.6e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTT1—glaucoma	2.37e-06	2.6e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—glaucoma	2.3e-06	2.53e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—glaucoma	2.16e-06	2.38e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—glaucoma	2.04e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—glaucoma	2.04e-06	2.24e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—glaucoma	2.01e-06	2.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAV1—glaucoma	1.99e-06	2.19e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—glaucoma	1.9e-06	2.08e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1B1—glaucoma	1.89e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCA1—glaucoma	1.89e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAV1—glaucoma	1.88e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—glaucoma	1.87e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—glaucoma	1.51e-06	1.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—glaucoma	1.51e-06	1.66e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—glaucoma	1.42e-06	1.56e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—glaucoma	1.38e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—glaucoma	1.33e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—glaucoma	1.3e-06	1.43e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—glaucoma	1.24e-06	1.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAV1—glaucoma	1.23e-06	1.35e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—glaucoma	9.29e-07	1.02e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—glaucoma	8.5e-07	9.33e-06	CbGpPWpGaD
